TNG462

· Tango Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TNG462, covering 2026-04-21 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients [Phase 1, Phase 2]

See pricing